{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:17:39Z","timestamp":1793636259036,"version":"4.5.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T00:00:00Z","timestamp":1490313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"NHLBI and NIDDK of the NIH","award":["R01-HL69877"],"award-info":[{"award-number":["R01-HL69877"]}]},{"name":"NHLBI and NIDDK of the NIH","award":["1P01HL131471"],"award-info":[{"award-number":["1P01HL131471"]}]},{"name":"NHLBI and NIDDK of the NIH","award":["R01-DK098252"],"award-info":[{"award-number":["R01-DK098252"]}]},{"name":"Office of Orphan Products Development, United States Food and Drug Administration","award":["R01FD003896"],"award-info":[{"award-number":["R01FD003896"]}]},{"DOI":"10.13039\/100015195","name":"AGTC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015195","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ymthe.2017.03.029","type":"journal-article","created":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T21:02:57Z","timestamp":1491858177000},"page":"1387-1394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency"],"prefix":"10.1016","volume":"25","author":[{"given":"Christian","family":"Mueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwladys","family":"Gernoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha M.","family":"Gruntman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florie","family":"Borel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emer P.","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Calcedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshid N.","family":"Rouhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Yachnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Campbell-Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Chulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Trapnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel G.","family":"McElvaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence R.","family":"Flotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2017.03.029_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/joim.12239","article-title":"Role of alpha-1 antitrypsin in human health and disease","volume":"276","author":"de Serres","year":"2014","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.ymthe.2017.03.029_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.0954-6820.1978.tb08452.x","article-title":"Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z","volume":"204","author":"Larsson","year":"1978","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.ymthe.2017.03.029_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1378\/chest.110.1.78","article-title":"Alpha 1-antitrypsin deficiency deaths in the United States from 1979-1991. An analysis using multiple-cause mortality data","volume":"110","author":"Browne","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.ymthe.2017.03.029_bib4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1006\/bbrc.1994.2565","article-title":"Expression of human alpha 1-antitrypsin in mouse after in\u00a0vivo gene transfer to hepatocytes by small liposomes","volume":"204","author":"Ali\u00f1o","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2017.03.029_bib5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/hum.1996.7.4-531","article-title":"Human alpha 1-antitrypsin gene transfer to in\u00a0vivo mouse hepatocytes","volume":"7","author":"Ali\u00f1o","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.029_bib6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/0006-2952(96)00038-X","article-title":"Long-term expression of the human alpha1-antitrypsin gene in mice employing anionic and cationic liposome vectors","volume":"51","author":"Crepso","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymthe.2017.03.029_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-2952(97)00872-1","article-title":"Long-term expression of the human alpha1-antitrypsin gene in mice employing anionic and cationic liposome vector","volume":"54","author":"Ali\u00f1o","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymthe.2017.03.029_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1165\/ajrcmb.10.1.8292378","article-title":"Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits","volume":"10","author":"Canonico","year":"1994","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ymthe.2017.03.029_bib9","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/10430340050015338","article-title":"Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin-deficient subjects: comparison with protein therapy","volume":"11","author":"Brigham","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.029_bib10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ymthe.2004.08.022","article-title":"Intrapleural administration of a serotype 5 adeno-associated virus coding for alpha1-antitrypsin mediates persistent, high lung and serum levels of alpha1-antitrypsin","volume":"10","author":"De","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.03.029_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1165\/ajrcmb.12.4.7695917","article-title":"Polarity of secretion of alpha 1-antitrypsin by human respiratory epithelial cells after adenoviral transfer of a human alpha 1-antitrypsin cDNA","volume":"12","author":"Siegfried","year":"1995","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ymthe.2017.03.029_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/humc.2013.168","article-title":"Intrapleural administration of an AAVrh.10 vector coding for human \u03b11-antitrypsin for the treatment of \u03b11-antitrypsin deficiency","volume":"24","author":"Chiuchiolo","year":"2013","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2017.03.029_bib13","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/hum.2011.053","article-title":"Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing \u03b11-antitrypsin: interim results","volume":"22","author":"Flotte","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.029_bib14","doi-asserted-by":"crossref","first-page":"14384","DOI":"10.1073\/pnas.95.24.14384","article-title":"Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors","volume":"95","author":"Song","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.029_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/mthe.2002.0673","article-title":"Intramuscular administration of recombinant adeno-associated virus 2 alpha-1 antitrypsin (rAAV-SERPINA1) vectors in a nonhuman primate model: safety and immunologic aspects","volume":"6","author":"Song","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.03.029_bib16","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1089\/hum.2006.17.1177","article-title":"Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults","volume":"17","author":"Brantly","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.029_bib17","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/mt.2011.292","article-title":"Sustained miRNA-mediated knockdown of mutant AAT with simultaneous augmentation of wild-type AAT has minimal effect on global liver miRNA profiles","volume":"20","author":"Mueller","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.03.029_bib18","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1172\/JCI70314","article-title":"Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression","volume":"123","author":"Mueller","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2017.03.029_bib19","doi-asserted-by":"crossref","first-page":"16363","DOI":"10.1073\/pnas.0904514106","article-title":"Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy","volume":"106","author":"Brantly","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.029_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jim.2015.06.011","article-title":"Dissociation of skeletal muscle for flow cytometric characterization of immune cells in macaques","volume":"425","author":"Liang","year":"2015","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ymthe.2017.03.029_bib21","doi-asserted-by":"crossref","first-page":"217ra1","DOI":"10.1126\/scitranslmed.3007116","article-title":"The circulating proteinase inhibitor \u03b1-1 antitrypsin regulates neutrophil degranulation and autoimmunity","volume":"6","author":"Bergin","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2017.03.029_bib22","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.4049\/jimmunol.1402739","article-title":"Therapeutic regulatory T\u00a0cells subvert effector T\u00a0cell function in inflamed islets to halt autoimmune diabetes","volume":"194","author":"Mahne","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2017.03.029_bib23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/357605a0","article-title":"The mechanism of Z alpha 1-antitrypsin accumulation in the liver","volume":"357","author":"Lomas","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2017.03.029_bib24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1042\/cs0860489","article-title":"Loop-sheet polymerization: the structural basis of Z alpha 1-antitrypsin accumulation in the liver","volume":"86","author":"Lomas","year":"1994","journal-title":"Clin. Sci."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617301296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617301296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:49:17Z","timestamp":1761500957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001617301296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1525001617301296"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.03.029","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s).","name":"copyright","label":"Copyright"}]}}